Gentiva Reports Fourth Quarter and Fiscal 20...(------ ------------ --...)

Date:2/18/2009

------ ------------ ------------ Cash and cash equivalents $69,201 $14,167 Restricted cash - 22,014 Short-term investments (B) - 31,250 Accounts receivable, net (C) 177,201 207,801 Deferred tax assets 11,933 18,859 Prepaid expenses and other current assets 13,141 14,415 ------ ------ Total current assets 271,476 308,506 Long-term investments (B) 11,050 - Note receivable 25,000 - Investment in affiliate 23,264 - Fixed assets, net 63,815 59,562 Intangible assets, net 250,432 211,602 Goodwill 308,213 276,100 Other assets 20,247 26,463 ------ ------ Total assets $973,497 $882,233 ======== ======== LIABILITIES AND SHAREHOLDERS' EQUITY --------------- Current portion of long-term debt $- $2,304 Accounts payable 8,027 20,093 Payroll and related taxes 17,869 17,163 Deferred revenue 32,976 29,015 Medicare liabilities 6,680 7,985 Cost of claims incurred but not reported - 24,321 Obligations under insurance programs 39,628 36,816 Other accrued expenses 40,895 42,282 ------ ------ Total current liabilities 146,075
'/>"/>

SOURCE Gentiva Health Services, Inc. Copyright©2009 PR Newswire. All rights reserved

1 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Related biology technology :

1. Gentiva Reports Strong Second Quarter led by Home Health Segment
2. Water Street Health Care Partners Completes Agreement With Gentiva Health Services to Acquire Majority Ownership of CareCentrix
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. QMed, Inc. Reports July Medicare SNP Enrollments
5. Phlo Affiliate Reports Expanded Coverage to Oregon Border
6. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
7. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
8. Carrington Reports Second Quarter 2007 Results
9. Avitar Reports Third Quarter Financial Results for Fiscal 2007
10. Response Genetics Reports Second Quarter 2007 Financial Results
11. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results